Page 4354 - Markets News

Spadework on for new types of bonds

Municipal, Sukuk & covered bonds on agenda, with aim to allow trading in these before FY15 gets over

Some progress in MFs' outreach beyond top cities

Industry's investors' awareness drive helps crack hinterland

What to buy this poll season

Nervousness ahead of the election outcome on May 16 may keep markets volatile, but experts say investors can pick up stocks across sectors

Sensex falls for 2nd day as profit-taking weighs

Jet Airways slips 3% on buzz Etihad may not make open offer

Today's picks

Nifty, Bank Nifty, Aurobindo Pharma, BHEL & Hindalco

Govt may ease IPO norms, tax code

Market on backfoot amid Ukraine fears; FIIs remain resilient

Foreign institutional investors (FIIs) bought shares worth a net Rs 295.01 crore on Friday, as per provisional data from the stock exchanges.

Markets end lower amid weak Asian cues

Markets ended lower, amid a range-bound trade, tracking weakness among Asian peers

Provisional: Markets end lower amid rangebound trade

Markets ended lower, amid range bound trade, tracking weakness among Asian peers.

Ambuja Cements, ACC extend weakness post March quarter results

Ambuja Cements was down 4% to Rs 201 and ACC by 2% at Rs 1,282 on the Bombay Stock Exchange.

Pharma shares buck weak market trend

Markets continued to trade weak tracking their Asian peers

Pharma shares in demand

Strides Arcolab, Fulford India, Wockhardt, Cipla, Divi's Lab, Ranbaxy, Aurobindo, Dr Reddy's, Lupin and Sun Pharma are up 2-20% on the BSE.

Markets remain volatile in a narrow range; Pharma gains

The market breadth in BSE remains marginally negative with 1,255 shares declining and 1,197 shares advancing.

Web special: Nifty futures to trade between 6,700-6,900

Check out the F&O trends in select stocks with Navneet Daga, Derivative Analyst at KR Choksey Securities

Wockhardt rallies as HP revokes drug suspension

The stock has rallied 10% to Rs 711 after the company said the regulator in Himachal Pradesh has revoked the suspension the manufacture and sale of a product.

Jain Irrigation hits 52-week high on heavy volumes

The stock has rallied over 35% in the past one month, compared with a 3% rise in benchmark CNX Nifty.

Lupin touches new high after joint venture with Japan's Yoshindo

The pharma stock has rallied 5% in the past four trading sessions compared with a 1% decline in benchmark CNX Nifty.

Nifty hovers around 6,750; financials drag

ICICI Bank, HDFC, L&T and Tata Motors among the top losers

UPL surges on robust Q4 numbers

The Q4 adjusted net profit up 28% y-o-y at Rs 405 crore, mainly due to higher operational income and lower employee costs.